Please login to the form below

Not currently logged in
Email:
Password:

Allergan appoints Douglas Ingram as first president

Promotion for company veteran

Allergan-Douglas-IngramAllergan has appointed company veteran Douglas Ingram as the company's first president.

Ingram, who has spent 17 years at Allegan, will lead the company's global commercial operations, holding responsibility for a product portfolio that includes Botox as well as several ophthalmology treatments.

He most recently spent three years as executive VP and president, Europe, Africa and Middle East (EAME).

Other roles during his extensive period at Allergan include chief administrative officer and chief ethics officer.

He rose to these roles having joined the company as senior attorney and chief litigation officer in 1996.

Before joining Allergan, Ingram was an attorney with Gibson, Dunn & Crutcher from 1988, practicing in the area of complex commercial litigation.

"Doug has built an impressive record of accomplishment and is widely regarded throughout our organisation as a leader who is committed to the highest standards of excellence in all areas,” said David Pyott, chairman of the board and CEO, Allergan.

27th June 2013

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Wisepress

Wisepress is a medical bookseller promoting and selling books worldwide, both online and via the 200 European medical conferences that...

Latest intelligence

Precision paediatrics: Treating patients with CAR-T
Dr Stuart Adams specialises in using T-cell therapy to treat paediatric patients at Great Ormond Street Hospital. Here, he explains what it was like to develop and deliver a groundbreaking...
What does it mean to be an agile organisation
We spoke with Philip Atkinson to learn how healthcare and pharmaceutical companies can rapidly respond to changes in the market....
Battling breast cancer with precision medicine (Part 2)
Dr Mark Moasser treated breast cancer survivor Laura Holmes-Haddad (interviewed in part one) with an innovative precision medicine, which at the time was yet to be approved. Here he gives...

Infographics